These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24675844)

  • 21. Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer.
    Di Pasqua AJ; Yuan H; Chung Y; Kim JK; Huckle JE; Li C; Sadgrove M; Tran TH; Jay M; Lu X
    J Nucl Med; 2013 Jan; 54(1):111-6. PubMed ID: 23100452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage cell tracking PET imaging using mesoporous silica nanoparticles via in vivo bioorthogonal F-18 labeling.
    Jeong HJ; Yoo RJ; Kim JK; Kim MH; Park SH; Kim H; Lim JW; Do SH; Lee KC; Lee YJ; Kim DW
    Biomaterials; 2019 Apr; 199():32-39. PubMed ID: 30735894
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Dias GM; Ramogida CF; Rousseau J; Zacchia NA; Hoehr C; Schaffer P; Lin KS; Bénard F
    Nucl Med Biol; 2018 Mar; 58():1-7. PubMed ID: 29291493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting.
    Pérez-Medina C; Abdel-Atti D; Zhang Y; Longo VA; Irwin CP; Binderup T; Ruiz-Cabello J; Fayad ZA; Lewis JS; Mulder WJ; Reiner T
    J Nucl Med; 2014 Oct; 55(10):1706-11. PubMed ID: 25060196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles.
    Zhang J; Li X; Rosenholm JM; Gu HC
    J Colloid Interface Sci; 2011 Sep; 361(1):16-24. PubMed ID: 21689824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.
    Huang X; Li L; Liu T; Hao N; Liu H; Chen D; Tang F
    ACS Nano; 2011 Jul; 5(7):5390-9. PubMed ID: 21634407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative and correlative biodistribution analysis of
    Kramer L; Winter G; Baur B; Kuntz AJ; Kull T; Solbach C; Beer AJ; Lindén M
    Nanoscale; 2017 Jul; 9(27):9743-9753. PubMed ID: 28678239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vivo Characterization of Platinum(II)-Based Linker Technology for the Development of Antibody-Drug Conjugates: Taking Advantage of Dual Labeling with
    Muns JA; Montserrat V; Houthoff HJ; Codée-van der Schilden K; Zwaagstra O; Sijbrandi NJ; Merkul E; van Dongen GAMS
    J Nucl Med; 2018 Jul; 59(7):1146-1151. PubMed ID: 29496986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies.
    Zeglis BM; Lewis JS
    J Vis Exp; 2015 Feb; (96):. PubMed ID: 25741890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).
    Deri MA; Ponnala S; Zeglis BM; Pohl G; Dannenberg JJ; Lewis JS; Francesconi LC
    J Med Chem; 2014 Jun; 57(11):4849-60. PubMed ID: 24814511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extra-Large Pore Mesoporous Silica Nanoparticles for Directing in Vivo M2 Macrophage Polarization by Delivering IL-4.
    Kwon D; Cha BG; Cho Y; Min J; Park EB; Kang SJ; Kim J
    Nano Lett; 2017 May; 17(5):2747-2756. PubMed ID: 28422506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Liu G; Zheng D; Tian X
    Int J Pharm; 2013 Mar; 445(1-2):12-9. PubMed ID: 23384728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.
    Guillet-Nicolas R; Laprise-Pelletier M; Nair MM; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Kleitz F; Fortin MA
    Nanoscale; 2013 Dec; 5(23):11499-511. PubMed ID: 24178890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice.
    Karmani L; Labar D; Valembois V; Bouchat V; Nagaswaran PG; Bol A; Gillart J; Levêque P; Bouzin C; Bonifazi D; Michiels C; Feron O; Grégoire V; Lucas S; Vander Borght T; Gallez B
    Contrast Media Mol Imaging; 2013; 8(5):402-8. PubMed ID: 23740810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid surface modifications increase mesoporous silica nanoparticle labeling properties in mesenchymal stem cells.
    Rosenbrand R; Barata D; Sutthavas P; Mohren R; Cillero-Pastor B; Habibovic P; van Rijt S
    Int J Nanomedicine; 2018; 13():7711-7725. PubMed ID: 30538454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational Design, Development, and Stability Assessment of a Macrocyclic Four-Hydroxamate-Bearing Bifunctional Chelating Agent for
    Seibold U; Wängler B; Wängler C
    ChemMedChem; 2017 Sep; 12(18):1555-1571. PubMed ID: 28715615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fully Automated
    Poot AJ; Adamzek KWA; Windhorst AD; Vosjan MJWD; Kropf S; Wester HJ; van Dongen GAMS; Vugts DJ
    J Nucl Med; 2019 May; 60(5):691-695. PubMed ID: 30530830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of
    Rousseau J; Zhang Z; Dias GM; Zhang C; Colpo N; Bénard F; Lin KS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):708-712. PubMed ID: 28131709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.
    Zhang Y; Zhi Z; Jiang T; Zhang J; Wang Z; Wang S
    J Control Release; 2010 Aug; 145(3):257-63. PubMed ID: 20450945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.